Oculogica Announces New Category 3 CPT Code Created by American Medical Association
October 29, 2019 07:45 ET
|
Oculogica, Inc.
NEW YORK, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Oculogica, Inc., a pioneer in algorithm-based neuro-diagnostics for brain health, announced today that the American Medical Association (AMA) has...
FDA Accepts SHINKEI Therapeutics Investigational New Drug Application for MR-301 for Traumatic Brain Injury
August 28, 2019 08:00 ET
|
SHINKEI Therapeutics
PRINCETON, N.J., Aug. 28, 2019 (GLOBE NEWSWIRE) -- SHINKEI Therapeutics., a clinical stage pharmaceutical company focused on the development of therapeutic drugs for the treatment of Central Nervous...
Craig Earns Top 10 Ranking for 30th Straight Year
August 05, 2019 18:55 ET
|
Craig Hospital
Englewood, Colo. , Aug. 05, 2019 (GLOBE NEWSWIRE) -- U.S. News & World Report has announced that Craig Hospital was ranked a top 10 rehabilitation hospital in the U.S. for the 30th consecutive...
Study Finds First Effective Scalable Intervention for Mild Traumatic Brain Injury
May 16, 2019 07:55 ET
|
Posit Science
WASHINGTON D.C., May 16, 2019 (GLOBE NEWSWIRE) -- A study run at five military and veterans’ hospitals has identified the first highly-scalable intervention for addressing cognitive deficits that...
Endonovo Therapeutics Announces Steven Ford as V.P. Marketing
May 07, 2019 09:20 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, May 07, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced, Steven Ford will be joining the company as Vice President of Marketing. In his position,...
Exactus Applauds Executive Chairman, Jonathan Gilbert on Launch of Impact Biosciences Corp.
April 08, 2019 06:30 ET
|
Exactus, Inc.
DELRAY BEACH, Fla., April 08, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB: EXDI), a healthcare company pursuing opportunities in Hemp derived Cannabidiol (CBD) products, applauds its Executive...
Endonovo Therapeutics Announces Partnership with Second Hospital
March 29, 2019 08:00 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA , March 29, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), today announced an agreement with a nationally recognized hospital group...
Endonovo Therapeutics Granted Trademarks for WoundPulse and OrthoHalo
March 22, 2019 08:00 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, March 22, 2019 (GLOBE NEWSWIRE) -- March 22, 2019 -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive...
Endonovo Therapeutics Partners with SunMED Medical Systems
March 20, 2019 08:00 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, March 20, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), Alan Collier, Endonovo’s Chief Executive Officer, stated "We are...
International Stem Cell Corporation Publishes Successful Results in Traumatic Brain Injury
February 13, 2019 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...